Reuters logo
BRIEF-Health Canada approves Otsuka and Lundbeck's REXULTI as a treatment for schizophrenia in adults
2017年2月17日 / 晚上10点11分 / 9 个月前

BRIEF-Health Canada approves Otsuka and Lundbeck's REXULTI as a treatment for schizophrenia in adults

Feb 17 (Reuters) - H Lundbeck A/S

* Health Canada approves Otsuka and Lundbeck’s REXULTI(tm) (brexpiprazole) as a treatment for schizophrenia in adults

* Lundbeck Canada - REXULTI will be co-marketed by two companies and is expected to become commercially available in Canada this spring Source text: [bit.ly/2kxY0C9] Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below